Literature DB >> 11985672

Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.

Kazuo Yamakami1, Shinkichi Akao, Takushi Tadakuma, Yoshio Nitta, Jyun-Ichi Miyazaki, Nobuyuki Yoshizawa.   

Abstract

BALB/c mice are susceptible to developing an infection with Leishmania major as a result of a fatal T helper 2 (Th2)-type response. However, mice infected with a low dose of parasites are reported to be able to overcome the lesions associated with a T helper 1 (Th1)-type response. To clarify why a difference in the dose of parasites induces a difference in the polarization of the Th phenotype, we first attempted to measure cytokine production. Soon after infection, the mice given high doses of parasites produced elevated levels of both Th1 [interferon-gamma (IFN-gamma)] and Th2 [interleukin (IL)-4 and IL-10] cytokines. However, when assessed at 1 and 2 weeks after infection, no significant difference in the balance of Th1 and Th2 cytokines could be detected between mice infected with low or high doses of L. major. These results support the notion that the Th2 cytokine levels at an early phase of infection could be a key factor for the induction of a Th2 response. In order to assess the efficacy of Th2 cytokines, the mice infected with low doses of L. major were co-administered IL-4 plasmid and IL-10 plasmid. Consequently, the mice (which originally exhibited a Th1 response) showed progressive disease and developed a Th2 response. However, administration of these plasmids at 7 days postinfection could not alter the Th polarization. Furthermore, production of IL-12 from the spleen cells stimulated by L. major was suppressed in the presence of IL-4 and IL-10. These results strongly suggest that the susceptibility to L. major in BALB/c mice depends on the persistence of Th2 cytokine levels at an early phase of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985672      PMCID: PMC1782681          DOI: 10.1046/j.1365-2567.2002.01394.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

Authors:  P A Bretscher; G Wei; J N Menon; H Bielefeldt-Ohmann
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

2.  In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.

Authors:  H Himmelrich; P Launois; I Maillard; T Biedermann; F Tacchini-Cottier; R M Locksley; M Röcken; J A Louis
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

3.  Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.

Authors:  F Powrie; S Menon; R L Coffman
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

4.  Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses.

Authors:  T Morokata; J Ishikawa; T Yamada
Journal:  Immunol Lett       Date:  2000-05-01       Impact factor: 3.685

5.  Early in vitro priming of distinct T(h) cell subsets determines polarized growth of visceralizing Leishmania in macrophages.

Authors:  N A Gomes; V Barreto-de-Souza; G A DosReis
Journal:  Int Immunol       Date:  2000-09       Impact factor: 4.823

6.  The antigen dose determines T helper subset development by regulation of CD40 ligand.

Authors:  C Ruedl; M F Bachmann; M Kopf
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

7.  IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.

Authors:  M van Den Broek; M F Bachmann; G Köhler; M Barner; R Escher; R Zinkernagel; M Kopf
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

8.  Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice.

Authors:  M D Sadick; N Street; T R Mosmann; R M Locksley
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.

Authors:  J P Sypek; C L Chung; S E Mayor; J M Subramanyam; S J Goldman; D S Sieburth; S F Wolf; R G Schaub
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  6 in total

1.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

2.  Inhalative IL-10 attenuates pulmonary inflammation following hemorrhagic shock without major alterations of the systemic inflammatory response.

Authors:  Philipp Kobbe; Philipp Lichte; Helen Schreiber; Lucy Kathleen Reiss; Stefan Uhlig; Hans-Christoph Pape; Roman Pfeifer
Journal:  Mediators Inflamm       Date:  2011-10-20       Impact factor: 4.711

Review 3.  Regulatory T cells and parasites.

Authors:  T P Velavan; Olusola Ojurongbe
Journal:  J Biomed Biotechnol       Date:  2011-12-29

4.  Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice.

Authors:  Anita Masic; Ramona Hurdayal; Natalie E Nieuwenhuizen; Frank Brombacher; Heidrun Moll
Journal:  PLoS Negl Trop Dis       Date:  2012-07-03

5.  Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.

Authors:  Nicole Zimara; Menberework Chanyalew; Abraham Aseffa; Ger van Zandbergen; Bernd Lepenies; Maximilian Schmid; Richard Weiss; Anne Rascle; Anja Kathrin Wege; Jonathan Jantsch; Valentin Schatz; Gordon D Brown; Uwe Ritter
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

6.  Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.

Authors:  Susana Mendez; Stacie K Reckling; Ciriacco A Piccirillo; David Sacks; Yasmine Belkaid
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.